Provided by Tiger Fintech (Singapore) Pte. Ltd.

Summit Therapeutics PLC

28.52
-0.6100-2.09%
Post-market: 28.780.2870+1.01%19:58 EDT
Volume:2.24M
Turnover:63.86M
Market Cap:21.18B
PE:-83.99
High:29.17
Open:29.17
Low:28.18
Close:29.13
Loading ...

Exchange-Traded Funds, Equity Futures Higher Pre-Bell Monday as Investors Focus on Inflation Data

MT Newswires Live
·
24 Feb

BUZZ-U.S. STOCKS ON THE MOVE-Nike, Domino's Pizza, Apple

Reuters
·
24 Feb

Summit Therapeutics Partners With Pfizer to Test Cancer Drug Combinations

MT Newswires Live
·
24 Feb

BRIEF-Summit Therapeutics Collaborates With Pfizer To Evaluate Ivonescimab Trial

Reuters
·
24 Feb

Summit Therapeutics, Pfizer to Study Ivonescimab/ADC Combos

Dow Jones
·
24 Feb

BUZZ-Summit Therapeutics rises on clinical trial collaboration with Pfizer

Reuters
·
24 Feb

Summit Therapeutics Q4 Net Loss Widens, Yearly Cash Equivalents Rise -- Shares Up Pre-Bell

MT Newswires Live
·
24 Feb

Stock Track | Summit Therapeutics Soars 6.69% Pre-market on Clinical Trial Collaboration with Pfizer

Stock Track
·
24 Feb

Earnings Flash (SMMT) Summit Therapeutics Posts Q4 Total Operating Expenses of $65.8M

MT Newswires Live
·
24 Feb

Summit Therapeutics Q4 2024 Adj EPS $(0.07) Beats $(0.08) Estimate

Benzinga
·
24 Feb

BRIEF-Summit Therapeutics Q4 Net Income USD -61.2 Million

Reuters
·
24 Feb

Summit Therapeutics Reports Financial Results and Operational Progress for the Fourth Quarter and Twelve Months Ended December 31, 2024

Business Wire
·
24 Feb

Summit Therapeutics Announces Clinical Trial Collaboration with Pfizer to Evaluate Ivonescimab in Combination with Pfizer Antibody Drug Conjugates (ADCs)

Business Wire
·
24 Feb

Insider Stock Buying Reaches US$78.8m On Summit Therapeutics

Simply Wall St.
·
23 Feb

Press Release: Summit Therapeutics to Host Fourth Quarter and Full Year 2024 Financial Results & Operational Progress Call on February 24, 2025

Dow Jones
·
18 Feb

Summit Therapeutics Inc expected to post a loss of 8 cents a share - Earnings Preview

Reuters
·
14 Feb

Why Summit Therapeutics Inc. (SMMT) Is Among the Best Healthcare Stocks To Buy According to Analysts

Insider Monkey
·
08 Feb

The Drug Industry Is Having Its Own DeepSeek Moment -- Heard on the Street -- WSJ

Dow Jones
·
07 Feb